Cerebras stock (CBRS) had one of the loudest US tech IPO debuts in years on Nasdaq this week. The AI chipmaker priced its IPO at $185 a share, opened at $385, and closed Day 1 near $311 on very heavy retail flow.
That is a 68% close above the offer price and a 108% pop at the open print on Thursday. According to TechCrunch, Cerebras raised about $5.55 billion by selling 30 million shares in the upsized, heavily oversubscribed offering.
The big question for investors right now is simple. Is CBRS stock a buy here at $311, or is this the moment to wait, watch the lockup, and pick a better spot in 2026?
Cerebras Profile and IPO Day Mechanics
What Cerebras Actually Sells
Cerebras builds custom AI training and inference chips, and its flagship product today is the Wafer Scale Engine 3 supercomputer. The WSE-3 is the largest commercial AI processor ever shipped, packing 4 trillion transistors onto a single 5nm wafer of TSMC silicon.
Per the Cerebras press release, the chip packs 900,000 AI-optimized cores and 44GB of fast on-chip SRAM memory bandwidth. That is roughly 57 times the active silicon area of Nvidia's flagship H100 GPU on a like-for-like die comparison.
Marquee customers today include OpenAI, Meta, Amazon Web Services, the UAE-backed G42, and Mayo Clinic. The thesis here is straightforward, since modern AI inference workloads need cheaper, faster, and more power-efficient silicon than GPUs alone can deliver at hyperscale.
IPO Pricing and Day 1 Tape
The IPO priced at $185, well above the initial $115 to $125 range and the later $150 to $160 marketing range. The deal sold 30 million shares and raised about $5.55 billion at a $56 billion fully diluted valuation at the offer price.
According to CNBC, the stock opened at $385, traded 108% above offer in heavy volume, then cooled to $311 by the bell. That put the Day 1 market cap near $67 billion and the trailing price-to-sales multiple at roughly 130 times annual sales.
Financials, Lockup, and the Buy or Wait Call
Revenue Growth and the Margin Swing
The financial story is by far the cleanest part of the pitch on this name today. Revenue jumped 76% to $510 million in 2025, building on similar growth the prior year and validating real, durable inference demand from hyperscale customers.
Per The Motley Fool, Cerebras swung near break-even on operating cash flow in 2025, from a $481.6 million net loss in 2024. The operating loss also narrowed sharply to about $146 million for the year, a meaningful step toward sustainable GAAP profitability over the next few quarters.
Lockup Calendar and Insider Supply Risk
The 180-day insider lockup on CBRS stock is set to expire around mid-November 2026 on the standard IPO clock. CEO Andrew Feldman alone holds roughly $1.9 billion in stock at the offer price, with co-founder and CTO Sean Lie at about $1 billion.
If CBRS holds above $300 a share into November, the post-lockup supply math gets very uncomfortable for new public-market buyers. Insiders sitting on multi-bagger paper gains tend to trim aggressively, and that overhang is the single biggest near-term risk on the name today.
Buy, Wait, or Trade the Range
If you want AI chip exposure today, the honest answer is to wait. However, CBRS is listed on the Gotrade platform, so direct retail exposure to the Cerebras IPO is available to Gotrade users this week.
The cleanest tradable proxy on Gotrade today is NVDA, which still owns roughly 85% to 90% of data center accelerator share globally. AMD and AVGO round out the basket, alongside our broader AI chip stock comparison piece for portfolio sizing decisions.
Conclusion
Cerebras is the most credible Nvidia challenger to hit US public markets in years, but the IPO tape is doing what IPO tapes always do. Retail pushed the open to $385, the deal cooled to $311 on Day 1, and the next test is two earnings prints plus the lockup.
For investors who want the AI semiconductor thesis in their portfolio right now, the Gotrade app runs through NVDA, AMD, and AVGO at sensible weights. CBRS belongs on the watchlist until it lists on Gotrade and clears its 180-day lockup window in late 2026, then a fresh look makes sense.
FAQ
Can I buy Cerebras (CBRS) stock on Gotrade today?
Yes, CBRS is available on the Gotrade platform.
What was the Cerebras IPO price and Day 1 close?
Cerebras priced its IPO at $185 per share, opened trading at $385 on Nasdaq, then closed Day 1 at roughly $311 for a 68% gain.
How big is Cerebras compared to Nvidia after Day 1?
Cerebras has a Day 1 market cap near $67 billion versus Nvidia at roughly $5.7 trillion, making Nvidia about 85 times larger today.
When does the Cerebras IPO lockup expire and why does it matter?
The 180-day insider lockup expires around mid-November 2026 and could unlock significant insider selling pressure on the freshly-listed CBRS stock.
What is the closest AI chip stock to Cerebras right now?
NVDA is the cleanest proxy for the AI accelerator thesis on Gotrade today, with AMD and AVGO as complementary AI semiconductor portfolio plays.
